Yeditepe University Hospital
Istanbul, 34752, Turkey (Türkiye)
NCT Number: NCT02022488
Investigators evaluated the effect of intranasal ketamine or alfentanil addition to oral midazolam for prevention of emergence agitation.Seventy-eight, 1-8 year-old children, undergoing urological surgery with sevoflurane anesthesia was included in the study. All the children received oral midazolam 0.5 mg/kg 40 minutes before anesthesia induction then enrolled to one of the study groups, randomly. Ketamine group (Group MK; n=26) patients were given 2mg/kg intranasal ketamine whereas, alfentanil group (Group MA; n=25) were given 10microgram/kg intranasal alfentanil 8-10 min before the induction of anesthesia. Saline group (Group MS; n=27) received intranasal isotonic saline.Parental separation, mask acceptance were evaluated with a 4- point scale. Emergence agitation was evaluated with Pediatric Anesthesia Emergence Delirium score.
Looking for future studies?
Notify Me1 year–8 year
All sexes
Interventional
Phase 4
Istanbul, 34752, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group M
Group MA
Group MK
Time frame: 7 months
Emergence agitation was evaluated using the Pediatric Anesthesia Emergence Delirium (PAED) score
Time frame: 7 months
Parental separation were evaluated with a 4- point scale in the preoperative period
Time frame: 7 months
The ease of mask acceptance were evaluated with a 4- point scale in the preoperative period
Yeditepe University Hospital
Other
Prevention of Emergence Agitation in Children After Sevoflurane Anesthesia With Ketamine-midazolam Combination: A Prospective Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07645521
Chronic Rhinosinusitis (CRS), Confusion
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsNCT07630922
Confusion, Delirium
Zhengzhou, Henan, China
View Trial DetailsNCT07304206
Confusion, Delirium
Malatya, Turkey (Türkiye)
View Trial DetailsNCT07082894
Adenotonsillectomy, Confusion
Tanta, Gharbia Governorate, Egypt
View Trial Details